Diabetes is associated with elevated mortality, stroke, and osteoradionecrosis in squamous cell carcinomas of the head and neck: a systematic review and meta-analysis
Abstract
Background: Diabetes mellitus has been associated with an increased incidence and potentially with a worse prognosis of squamous cell carcinomas due to chronic inflammation, oxidative stress, and metabolic reprogramming, which promote tumor growth and therapy resistance. Furthermore, it impairs immune response and posttreatment healing, potentially leading to higher complication rates.
Methods: The study protocol was preregistered (CRD42025634653). An electronic search was conducted in MEDLINE, Embase, and Cochrane. Studies on patients with squamous cell carcinomas were included to compare survival metrics and complication rates with and without diabetes. Hazard ratios, odds ratios, and mean differences were extracted. A random-effects model was used, with subgroups based on cancer location.
Results: 63 predominantly retrospective studies met the inclusion criteria, with a population of 138,000 individuals. The meta-analysis found statistically significant differences in disease-specific (HR = 1.47 [1.11-1.96]; I2 = 60%), overall (HR = 1.31 [1.23-1.39]; I2 = 4%), and disease-free survival (HR = 1.58 [1.12-2.24]; I2 = 58%); the subgroup analysis revealed that diabetes significantly affected oral and oropharyngeal subsites. Posttreatment stroke (HR = 2.11 [1.15-3.87]; I2 = 70%) and osteoradionecrosis rates (HR = 2.2 [1.38-3.53]; I2 = 11%) were significantly elevated.
Conclusion: Diabetes is associated with worse disease-specific survival in oral and oropharyngeal subtypes and…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 138,000 participants or records.
Read the paper
Related studies
- Metformin as an adjuvant in breast cancer treatment
- Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?
- Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice
- Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines
- Protein Interaction Network for Identifying Vascular Response of Metformin (Oral Antidiabetic)
- Preventing Long COVID With Metformin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.